APA aipamena

Buatois, V., Johnson, Z., Pires, S. S., Papaioannou, A., Hatterer, E., Chauchet, X., . . . Ferlin, W. G. (2018). Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia. Mol Cancer Ther.

Chicago Style aipamena

Buatois, Vanessa, et al. "Preclinical Development of a Bispecific Antibody That Safely and Effectively Targets CD19 and CD47 for the Treatment of B Cell Lymphoma and Leukemia." Mol Cancer Ther 2018.

MLA aipamena

Buatois, Vanessa, et al. "Preclinical Development of a Bispecific Antibody That Safely and Effectively Targets CD19 and CD47 for the Treatment of B Cell Lymphoma and Leukemia." Mol Cancer Ther 2018.